David Lally, MD, presented at the 2025 Retina Society meeting, discussing the ARCHER study (NCT04656561) of ANX007 for the treatment of age-related macular degeneration (AMD) and geographic atrophy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback